Suppr超能文献

双重ET(A)/ET(B)受体阻断对犬冠状动脉对跑步机运动反应的影响。

Influence of dual ET(A)/ET(B)-receptor blockade on coronary responses to treadmill exercise in dogs.

作者信息

Takamura M, Parent R, Cernacek P, Lavallée M

机构信息

Department of Medicine, Institut de Cardiologie de Montréal, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada H1T 1C8.

出版信息

J Appl Physiol (1985). 2000 Nov;89(5):2041-8. doi: 10.1152/jappl.2000.89.5.2041.

Abstract

We hypothesized that endothelin (ET) release during exercise may be triggered by alpha-adrenergic-receptor activation and thereby influence coronary hemodynamics and O(2) metabolism in dogs. Exercise resulted in coronary blood flow increases (to 1.88+/-0.26 from 1.10+/- 0.12 ml x min(-1) x g(-1)) and in a fall (P<0.01) in coronary sinus O(2) saturation (17.4+/-1.5 to 9.6+/-0.7 vol%), whereas myocardial O(2) consumption (MVO(2)) increased (109+/-13% from 145+/-16 microl O(2) min(-1) x g(-1)). Tezosentan, a dual ET(A)/ET(B)-receptor blocker, slightly reduced mean arterial pressure (MAP) and increased heart rate throughout exercise. The relationship between coronary sinus O(2) saturation and MVO(2) was shifted upward (P<0.05) after tezosentan administration; i.e., as MVO(2) increased during exercise, coronary sinus O(2) saturation was disproportionately higher after ET-receptor blockade. After propranolol, tezosentan resulted in significant decreases (P<0.05) in left ventricular pressure, the first derivative of left ventricular pressure over time, and MAP during exercise. As MVO(2) increased during exercise, coronary sinus O(2) saturation levels after tezosentan became superimposable over those observed before ET-receptor blockade. Thus dual blockade of ET(A)/ET(B) receptors alters coronary hemodynamics and O(2) metabolism during exercise, but ET activity failed to increase beyond baseline levels.

摘要

我们推测,运动过程中内皮素(ET)的释放可能由α-肾上腺素能受体激活触发,从而影响犬的冠状动脉血流动力学和氧代谢。运动导致冠状动脉血流量增加(从1.10±0.12 ml·min⁻¹·g⁻¹增至1.88±0.26),同时冠状窦氧饱和度下降(P<0.01)(从17.4±1.5降至9.6±0.7 vol%),而心肌氧消耗(MVO₂)增加(从145±16 μl O₂·min⁻¹·g⁻¹增至109±13%)。替唑生坦是一种ET(A)/ET(B)双重受体阻滞剂,在整个运动过程中使平均动脉压(MAP)略有降低并使心率增加。给予替唑生坦后,冠状窦氧饱和度与MVO₂之间的关系向上移动(P<0.05);即,在运动过程中随着MVO₂增加,ET受体阻断后冠状窦氧饱和度异常升高。给予普萘洛尔后,替唑生坦导致运动过程中左心室压力、左心室压力随时间的一阶导数和MAP显著降低(P<0.05)。随着运动过程中MVO₂增加,替唑生坦后的冠状窦氧饱和度水平变得与ET受体阻断前观察到的水平重叠。因此,ET(A)/ET(B)受体的双重阻断在运动过程中改变了冠状动脉血流动力学和氧代谢,但ET活性未能增加到基线水平以上。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验